Influenza B virus with modified hemagglutinin cleavage site as a novel attenuated live vaccine.

PubWeight™: 1.40‹?› | Rank: Top 5%

🔗 View Article (PMID 21917878)

Published in J Infect Dis on September 14, 2011

Authors

Jürgen Stech1, Holger Garn, Astrid Herwig, Olga Stech, Bianca Dauber, Thorsten Wolff, Thomas C Mettenleiter, Hans-Dieter Klenk

Author Affiliations

1: Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald, Insel Riems, Germany. juergen.stech@fli.bund.de

Articles citing this

Principles underlying rational design of live attenuated influenza vaccines. Clin Exp Vaccine Res (2012) 0.78

Tailor-made cleavage site attenuates influenza B. Expert Rev Vaccines (2012) 0.75

Articles by these authors

Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97

Novel orthobunyavirus in Cattle, Europe, 2011. Emerg Infect Dis (2012) 7.62

Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci U S A (2004) 7.18

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med (2005) 6.77

The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nat Neurosci (2004) 5.36

Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J Virol (2003) 5.11

Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol (2002) 5.09

The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol (2003) 4.73

Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature (2010) 4.23

IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A (2007) 3.98

New low-viscosity overlay medium for viral plaque assays. Virol J (2006) 3.92

Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol (2004) 3.43

Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus. PLoS Pathog (2008) 3.37

Pathogenesis and transmission of the novel swine-origin influenza virus A/H1N1 after experimental infection of pigs. J Gen Virol (2009) 3.09

Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J Virol (2004) 2.99

The interacting UL31 and UL34 gene products of pseudorabies virus are involved in egress from the host-cell nucleus and represent components of primary enveloped but not mature virions. J Virol (2002) 2.98

IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol (2006) 2.93

Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol (2006) 2.80

Ebola virus: from discovery to vaccine. Nat Rev Immunol (2003) 2.72

Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice. Cell (2011) 2.51

Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol (2007) 2.44

Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme. N Engl J Med (2015) 2.44

Influenza A viruses target type II pneumocytes in the human lung. J Infect Dis (2012) 2.38

Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1) 2009 influenza virus. J Virol (2010) 2.38

Complete, annotated sequence of the pseudorabies virus genome. J Virol (2004) 2.35

SARS--beginning to understand a new virus. Nat Rev Microbiol (2003) 2.30

Pause on avian flu transmission research. Science (2012) 2.24

Pseudorabies virus UL36 tegument protein physically interacts with the UL37 protein. J Virol (2002) 2.24

Physical interaction between envelope glycoproteins E and M of pseudorabies virus and the major tegument protein UL49. J Virol (2002) 2.19

The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J Virol (2002) 2.14

Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence. J Virol (2006) 2.14

Tracing from fat tissue, liver, and pancreas: a neuroanatomical framework for the role of the brain in type 2 diabetes. Endocrinology (2005) 2.10

Human box C/D snoRNAs with miRNA like functions: expanding the range of regulatory RNAs. Nucleic Acids Res (2010) 2.08

The UL48 tegument protein of pseudorabies virus is critical for intracytoplasmic assembly of infectious virions. J Virol (2002) 1.97

Molecular analysis of highly pathogenic avian influenza virus of subtype H5N1 isolated from wild birds and mammals in northern Germany. J Gen Virol (2007) 1.94

Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog (2008) 1.94

Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Cell Microbiol (2006) 1.94

Vesicle formation from the nuclear membrane is induced by coexpression of two conserved herpesvirus proteins. Proc Natl Acad Sci U S A (2007) 1.93

Entry of pseudorabies virus: an immunogold-labeling study. J Virol (2005) 1.87

Identification of Lassa virus glycoprotein signal peptide as a trans-acting maturation factor. EMBO Rep (2003) 1.85

Maternal TLR signaling is required for prenatal asthma protection by the nonpathogenic microbe Acinetobacter lwoffii F78. J Exp Med (2009) 1.79

Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells. Cell Microbiol (2006) 1.77

Macrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS Pathog (2013) 1.74

Ectodomain shedding of the glycoprotein GP of Ebola virus. EMBO J (2004) 1.73

Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection. J Virol (2008) 1.73

Essential function of the pseudorabies virus UL36 gene product is independent of its interaction with the UL37 protein. J Virol (2004) 1.73

Novel lyssavirus in Natterer's bat, Germany. Emerg Infect Dis (2011) 1.71

Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation. J Virol (2002) 1.71

Schmallenberg virus as possible ancestor of Shamonda virus. Emerg Infect Dis (2012) 1.70

The pseudorabies virus UL11 protein is a virion component involved in secondary envelopment in the cytoplasm. J Virol (2003) 1.69

Differential use of importin-α isoforms governs cell tropism and host adaptation of influenza virus. Nat Commun (2011) 1.65

Influenza-virus-induced signaling cascades: targets for antiviral therapy? Trends Mol Med (2003) 1.64

VP40, the matrix protein of Marburg virus, is associated with membranes of the late endosomal compartment. J Virol (2002) 1.63

The influenza B virus nonstructural NS1 protein is essential for efficient viral growth and antagonizes beta interferon induction. J Virol (2004) 1.61

Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling. Apoptosis (2007) 1.61

Failure to detect Borna disease virus antigen and RNA in human blood. J Clin Virol (2006) 1.59

NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation. J Biol Chem (2004) 1.59

Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci U S A (2006) 1.58

Phylogeny of the SARS coronavirus. Science (2003) 1.56

The suprachiasmatic nucleus balances sympathetic and parasympathetic output to peripheral organs through separate preautonomic neurons. J Comp Neurol (2003) 1.56

Identification and characterization of the pseudorabies virus tegument proteins UL46 and UL47: role for UL47 in virion morphogenesis in the cytoplasm. J Virol (2002) 1.56

Natural and synthetic sialic acid-containing inhibitors of influenza virus receptor binding. Rev Med Virol (2003) 1.51

Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1. Proc Natl Acad Sci U S A (2005) 1.49

Rac1 and PAK1 are upstream of IKK-epsilon and TBK-1 in the viral activation of interferon regulatory factor-3. FEBS Lett (2004) 1.47

Phosphorylation of VP30 impairs ebola virus transcription. J Biol Chem (2002) 1.47

Selective parasympathetic innervation of subcutaneous and intra-abdominal fat--functional implications. J Clin Invest (2002) 1.46

VP24 of Marburg virus influences formation of infectious particles. J Virol (2005) 1.46

Highly pathogenic avian influenza virus (H5N1) in experimentally infected adult mute swans. Emerg Infect Dis (2008) 1.45

Avian-virus-like receptor specificity of the hemagglutinin impedes influenza virus replication in cultures of human airway epithelium. Virology (2007) 1.44

Interplay between influenza A virus and the innate immune signaling. Microbes Infect (2009) 1.43

Oligomerization and polymerization of the filovirus matrix protein VP40. Virology (2003) 1.42

The nipah virus fusion protein is cleaved within the endosomal compartment. J Biol Chem (2005) 1.42

Simultaneous deletion of pseudorabies virus tegument protein UL11 and glycoprotein M severely impairs secondary envelopment. J Virol (2004) 1.42

Composition of pseudorabies virus particles lacking tegument protein US3, UL47, or UL49 or envelope glycoprotein E. J Virol (2006) 1.41

Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. J Virol (2010) 1.40

The pseudorabies virus US3 protein is a component of primary and of mature virions. J Virol (2004) 1.39

The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation. J Virol (2004) 1.39

Structure of a core fragment of glycoprotein H from pseudorabies virus in complex with antibody. Proc Natl Acad Sci U S A (2010) 1.38

The capsid-associated UL25 protein of the alphaherpesvirus pseudorabies virus is nonessential for cleavage and encapsidation of genomic DNA but is required for nuclear egress of capsids. J Virol (2006) 1.38

Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever. J Infect Dis (2007) 1.37

Rapid and reliable universal cloning of influenza A virus genes by target-primed plasmid amplification. Nucleic Acids Res (2008) 1.36

Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proc Natl Acad Sci U S A (2005) 1.36

Epidemiology of bluetongue virus serotype 8, Germany. Emerg Infect Dis (2009) 1.35

Acinetobacter lwoffii and Lactococcus lactis strains isolated from farm cowsheds possess strong allergy-protective properties. J Allergy Clin Immunol (2007) 1.33

The elimination of fox rabies from Europe: determinants of success and lessons for the future. Philos Trans R Soc Lond B Biol Sci (2013) 1.32

Allergic airway inflammation inhibits pulmonary antibacterial host defense. J Immunol (2006) 1.31

Homo-oligomerization of Marburgvirus VP35 is essential for its function in replication and transcription. J Virol (2005) 1.30

Influenza A virus replication induces cell cycle arrest in G0/G1 phase. J Virol (2010) 1.30

Receptor-binding profiles of H7 subtype influenza viruses in different host species. J Virol (2012) 1.29

N-Glycans attached to the stem domain of haemagglutinin efficiently regulate influenza A virus replication. J Gen Virol (2002) 1.29

Inclusion bodies are a site of ebolavirus replication. J Virol (2012) 1.29